Herceptin (Trastuzumab) for Breast Cancer Treatment
Herceptin (Trastuzumab) for Breast Cancer Treatment: Quick Links
Important Safety Information
Adjuvant Breast Cancer
Metastatic Breast Cancer
Full Prescribing Information
Switch to Healthcare Professionals
Share your Herceptin Story
Herceptin (Trastuzumab) and Breast Cancer: Patients and Caregivers
This site is intended for US Residents only. If you are not a US Resident, please click here.
Herceptin (Trastuzumab) Go to Patient and Caregiver Site Herceptin (Trastuzumab): Go to Healthcare Professional Site English  |   Español
Search this site: Text Size: Herceptin (Trastuzumab) for Breast Cancer Treatment: Increase Font Size Herceptin (Trastuzumab) for Breast Cancer Treatment: Decrease Font Size Herceptin (Trastuzumab) for Breast Cancer Treatment: Print Page Print Page Herceptin (Trastuzumab) for Breast Cancer Treatment: Email Page E-Mail Page
Herceptin (Trastuzumab) Breast Cancer: Heritage

Herceptin Resources | Insurance Information

We're here to help

Handling insurance matters can be difficult on your own. That's where Herceptin Access Solutions can help. Although you are not required to use this free information resource, you may find it reassuring to know that Herceptin Access Solutions is here for you if you need help with your insurance matters.

What is Herceptin Access Solutions?

Herceptin Access Solutions, sponsored by Genentech, Inc., is a free resource that can provide patients and their healthcare providers with helpful insurance reimbursement information regarding Herceptin®

Herceptin Access Solutions reimbursement specialists can offer you assistance with:

  • Investigating your Herceptin insurance coverage benefits
  • Assessing whether prior authorization, from your insurance, is needed for your Herceptin therapy
  • Appealing denied Herceptin claims
  • Providing patient assistance resources


You can access more information about Herceptin Access Solutions on the internet at www.HerceptinAccessSolutions.com, or speak to a Herceptin Access Solutions reimbursement specialist at:

Toll-free: 1-888-249-4918 (6 AM to 5 PM Pacific time Monday-Friday)

What if I don't have insurance?

Not all Herceptin® (Trastuzumab) patients have complete medical coverage, so we've provided some alternative resources.

Please note: This page contains the Web address to a number of other organizations that may offer useful information. We suggest visiting those sites directly to obtain information on specific details of coverage, and educational and financial support services for Herceptin. Unless otherwise indicated, Genentech, Inc. is not a partner or affiliated with any company listed. The availability of insurance coverage and financial assistance varies from company to company, plan to plan, and state to state. Genentech, Inc. does not imply or guarantee that your insurance company nor any other company will provide coverage or assistance for Herceptin. Genentech, Inc. is not responsible for any decisions of partial or noncoverage of Herceptin.

Genentech® Access to Care Foundation

Although Genentech's products are covered by most government and private insurance, Genentech has established the Genentech Access to Care Foundation for its marketed products.We are committed to eligible patients having access to all of our drugs for approved indications. For eligible patients who are treated in the United States, Genentech will provide product to those who cannot afford to pay because we believe it is the right thing to do.

Herceptin (Trastuzumab) Breast Cancer Resources: Print Page
Herceptin (Trastuzumab) for Breast Cancer Treatment: Privacy Policy Herceptin (Trastuzumab) for Breast Cancer Treatment: Terms and Conditions Herceptin (Trastuzumab) for Breast Cancer Treatment: Prescribing Information Herceptin (Trastuzumab) for Breast Cancer Treatment: Safety Information Herceptin (Trastuzumab) for Breast Cancer Treatment: Site Map Herceptin (Trastuzumab) for Breast Cancer Treatment: Contact Information
Genentech BioOncology © 2008 Genentech, Inc. All rights reserved. This site intended for US residents only.